PARP1 Knockout MCF7 Cell line

PARP1 Knockout MCF7 Cell line
Artikelnummer
BPS82690
Verpackungseinheit
2 vials
Hersteller
BPS Bioscience

Verfügbarkeit: wird geladen...
Preis wird geladen...
Products from BPS Bioscience require a minimum order value above 400€

Application: Use as a negative control when testing PARP1 inhibitors in MCF7 cells.Cellular model for studies on the role of PARP1.

Background: PARP1, also known as poly-(ADP-ribose) polymerase 1 or NAD+ ADP-ribosyltransferase 1, is part of the PARP family and the most abundant member. ADP ribosylation, which is the addition of an ADP-ribose to a protein, is a reversible post-translational modification of proteins mostly involved in the DNA Damage Response (DDR) pathway. Poly-ADP-ribosylation (termed PARylation) is the addition of linear or branched chains of ADP-ribose. PARP1 participates in DNA repair by non-homologous end joining (NHEJ), homologous recombination (HR), microhomology-mediated end-joining (MMEJ) and nucleotide excision repair. Dysfunction of DDR pathways can lead to oncogenesis. Overexpression of PARP1 has been found in breast and colon cancer, neuroblastoma, and others. This overexpression can lead to increasing MMEJ, an error-prone DNA repair mechanism, and genome instability leading to cancer. In addition to being involved in DDR, PARP1 is also linked to inflammation and type I diabetes. PARP1 inhibitors have been used in cancer treatment with success. The use of PARP1 inhibitors can lead to synthetic lethality when homologous recombination repair (HRR) mechanisms are already defective, as in the case of BRCA1 (breast cancer susceptibility protein type 1) and BRCA2-deficient cells. Further understanding of the molecular pathways involving PARP1, and their contribution to disease, will continue to pave the way for new therapies for PARP1-linked diseases.

Description: PARP1 Knockout MCF7 Cell Line is an MCF7 breast cancer cell line in which human PARP1 (Poly-(ADP-ribose) Polymerase 1) has been genetically removed using CRISPR/Cas9 genome editing.This cell line has been validated by genomic sequencing and Western Blot.

Host Cell Line: MCF7 human breast mammary gland cell line. Adherent epithelial cells

Mycoplasma Testing: The cell line has been screened to confirm the absence of Mycoplasma species.

Storage Stability: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage. Contact technical support at support@bpsbioscience.com if the cells are not frozen in dry ice upon arrival.

Supplied As: Each vial contains ˃1 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience #79796)

Uniprot: P09874

Warnings: Avoid freeze/thaw cycles

Biosafety Level: BSL-1

References: Marques M., et al., 2019 Oncogene 38 (12): 2177-2191.
Mehr Informationen
Artikelnummer BPS82690
Hersteller BPS Bioscience
Hersteller Artikelnummer 82690
Verpackungseinheit 2 vials
Mengeneinheit PAK
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF)
×